Health outcomes in pediatric rheumatic diseases

Current Opinion in Rheumatology

Volumn 16, Issue 2, 2004, Pages 102-108

  Duffy, Ciaran M ^a,b  

^a MONTREAL CHILDREN S HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Childhood lupus; Health outcomes; Juvenile dermatomyositis; Juvenile idiopathic arthritis; Juvenile rheumatoid arthritis

Indexed keywords

CORTICOSTEROID; ETANERCEPT; METHOTREXATE; RHEUMATOID FACTOR;

CANADA; CHILDHOOD DISEASE; CLINICAL TRIAL; COHORT ANALYSIS; DERMATOMYOSITIS; EUROPE; HUMAN; JUVENILE RHEUMATOID ARTHRITIS; MEDICAL RESEARCH; NUTRITIONAL STATUS; OSTEOPENIA; OUTCOMES RESEARCH; PHYSICAL DISABILITY; POLYARTHRITIS; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; REVIEW; SYSTEMIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME; UNITED STATES;

ADOLESCENT; ARTHRITIS; CHILD; DERMATOMYOSITIS; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; OUTCOME ASSESSMENT (HEALTH CARE); RHEUMATIC DISEASES;

EID: 1442323723     PISSN: 10408711     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002281-200403000-00005     Document Type: Review

References (56)

1. Duffy CM, Duffy KN: Health assessment in the rheumatic diseases of childhood. Curr Opin Rheumatol 1997, 9:440-447.
2. Duffy CM, Lovell DJ: Outcome assessment in paediatric rheumatic diseases. In Textbook of Pediatric Rheumatology. Edited by Cassidy J, Petty RE. Toronto: Saunders; 2001:189-199.
3. Murray KJ, Passo MH: Functional measures in children with rheumatic diseases. Pediatr Clin North Am 1995, 42:1127-1153.
4. Oen K: Long-term outcomes and predictors of outcomes for patients with juvenile idiopathic arthritis. Best Pract Res Clin Rheumatol 2002, 16:347-360. This recent review emphasizes predictors of outcome.
5. Feldman BM, Grundland B, McCullough L, et al.: Distinction of quality of life, health-related quality of life, and health status in children referred for rheumatology care. J Rheumatol 2000, 27:226-233.
6. Tucker LB: Whose life is it anyway? Understanding quality of life in children with rheumatic diseases. J Rheumatol 2000, 27:8-11.
7. Ravelli A, Martini A: Early predictors of outcome in juvenile idiopathic arthritis. Clin Exp Rheumatol 2003, 21 (suppl 31):S89-S93. This is an excellent review that emphasizes the predictors of outcome and damage in JIA.
8. Petty RE, Southwood TR, Baum J, et al.: Revision of the proposed classification criteria for juvenile idiopathic arthritis, 1997. J Rheumatol 1998, 25:1991-1994.
9. Coulton CJ, Zborowsky E, Lipton J, et al.: Assessment of the reliability and validity of the arthritis impact measurement scales for children with juvenile arthritis. Arthritis Rheum 1987, 30:819-824.
10. Lovell DJ, Howe S, Shear E, et al.: Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Scale. Arthritis Rheum 1989, 32:1390-1395.
11. Howe S, Levinson J, Shear E, et al.: Development of a disability measurement tool for juvenile rheumatoid arthritis. The Juvenile Arthritis Functional Assessment Report for children and their parents. Arthritis Rheum 1991, 34:873-880.
12. Singh G, Athreya BH, Fries JF, et al.: Measurement of health status in children with juvenile rheumatoid arthritis. Arthritis Rheum 1994, 37:1761-1769.
13. Wright FV, Law M, Goldsmith CH, et al.: Development of a self-report functional status index for juvenile rheumatoid arthritis. J Rheumatol 1994, 21:536-544.
14. Wright FV, Kimber JL, Law M, et al.: The juvenile arthritis functional status index (JASI): a validation study. J Rheumatol 1996, 23:1066-1079.
15. Duffy CM, Arsenault L, Duffy KNW, et al.: Level of agreement between parents and children in rating dysfunction in juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol 1993, 20:2134-2139.
16. Duffy CM, Arsenault L, Duffy KNW, et al.: The juvenile arthritis quality of life questionnaire - development of a new responsive index for juvenile rheumatoid arthritis and juvenile spondyloarthritides. J Rheumatol 1997, 24:738-746.
17. Tucker LB, De Nardo BA, Schaller JG: the childhood arthritis health profile: correlation of JRA-specific scales with disease severity and activity. Arthritis Rheum 1996, 39:S57.
18. Landgraf JM, Abetz L, Ware JE: Child Health Questionnaire (CHQ): A User's Manual. Boston: The Health Institute, New England Medical Center; 1996.
19. Varni JW, Seid M, Rode CA: The Peds QL: measurement model for the Pediatric Quality of Life Inventory. Med Care 1999, 37:126-139.
20. Ruperto N, Ravelli A, Pistorio A, et al.: Cross-cultural adaptation and psychometric evaluation of the Childhood Health Assessment Questionnaire (CHAQ) and the Child Health Questionnaire (CHQ) in 32 countries. Clin Exp Rheumatol 2001, 19(suppl 23):S1-S9.
21. Ruperto N, Murray K, Gerloni V, et al.: A randomized trial of methotrexate in medium versus high doses in children with juvenile idiopathic arthritis who failed on standard dose. Arthritis Rheum 2002, 49(suppl):S:232.
22. Varni JW, Seid M, Smith Knight T, et al.: The Peds QL in Pediatric Rheumatology. Reliability, validity and responsiveness of the Pediatric Quality of Life Inventory Generic Core Scales and Rheumatology Module. Arthritis Rheum 2002, 46:714-725. This is an excellent new measure of health-related quality of life in children that has broad application. This study validates its use in JIA.
23. Brunner HI, Lovell DJ, Finck BK, et al.: Preliminary definition of disease flare in juvenile rheumatoid arthritis. J Rheumatol 2002, 29:1058-1064. This is an important study that determined the appropriate definition of disease flare that should be applied in clinical trials in JIA.
24. Lovell DJ, Giannini EH, Reiff A, et al.: Etanercept in children with polyarticular juvenile rheumatoid arthritis. Pediatric Rheumatology Collaborative Study Group. N Engl J Med 2000, 342:763-769.
25. Giannini EH, Ruperto R: Ravelli A and the Paediatric Rheumatology International Trials Organization (PRINTO): Preliminary definition of improvement in juvenile arthritis. Arthritis Rheum 1997, 40:1202-1209.
26. Minden K, Kiessling U, Listing J, et al.: Prognosis of patients with juvenile chronic arthritis and juvenile spondyloarthropathy. J Rheumatol 2000, 27:2256-2263.
27. Oen K, Malleson P, Cabral D, et al.: Disease course and outcome of juvenile rheumatoid arthritis in a multicentre cohort. J Rheumatol 2002, 29:1989-1999. A very important study depicts the outcomes of a very large cohort of patients with JIA from three Canadian centers. This study demonstrates that disease activity persists into adulthood in a high proportion of cases and that outcomes are perhaps not as good as previously thought.
28. Guillaume S, Prieur AM, Coste J, et al.: Long-term outcome and prognosis in oligo-articular onset juvenile idiopathic arthritis. Arthritis Rheum 2000, 43:1858-1865.
29. Zak M, Pedersen FK: Juvenile chronic arthritis into adulthood: a long-term follow up study. Rheumatology 2000, 39:198-204.
30. Lomater C, Gerioni V, Gattinara M, et al.: Systemic onset juvenile idiopathic arthritis: a retrospective study of 80 consecutive patients followed for 10 years. J Rheumatol 2000, 27:491-496.
31. Fantini F, Gerioni V, Gattinara M, et al.: Remission in juvenile chronic arthritis: a cohort study of 683 consecutive cases with a mean 10 year follow up. J Rheumatol 2003, 30:579-584. A very large cohort study of an Italian population with a long duration of follow-up that also includes the spondyloarthropathies.
32. Flato B, Lien G, Smerdel A, et al.: Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years. J Rheumatol 2003, 30:386-393. A comprehensive study of a well-characterized Norwegian population that identifies specific genetic markers as predictors of outcome.
33. Foster HE, Marshall N, Myers A, et al.: Outcome in adults with juvenile idiopathic arthritis. Arthritis Rheum 2003, 48:767-775. This is an important study that illustrates the long-term social outcomes in an English population of adults with JIA, emphasizing higher rates of unemployment in this population.
34. Bowyer S, Roettcher PA, Higgins GC, et al.: Health status of patients with juvenile rheumatoid arthritis at 1 and 5 years after diagnosis. J Rheumatol 2003, 30:394-400. This US study looks at social outcomes, emphasizing education in children with JRA.
35. Ruperto N, Levinson JE, Ravelli A, et al.: Long-term health outcomes and quality of life in American and Italian inception cohorts of patients with juvenile rheumatoid arthritis. 1. Outcome status. J Rheumatol 1997, 24:945-951.
36. Spiegel LR, Schneider R, Lang BA, et al.: Early predictors of poor functional outcome in systemic onset juvenile rheumatoid arthritis: a multicentre cohort study. Arthritis Rheum 2000, 43:2402-2409.
37. Selvaag AE, Flato B, Lien G, et al.: Measuring health status in early juvenile idiopathic arthritis: determinants and responsiveness of the Child Health Questionnaire. J Rheumatol 2003, 30:1602-1610. A Norwegian study of short duration used the Child Health Questionnaire to estimate the physical and psychological status of their JIA population.
38. Oen K, Reed M, Malleson P, et al.: Radiologic outcome and its relationship to functional disability in juvenile rheumatoid arthritis. J Rheumatol 2003, 30:832-840. This very important study attempted to correlate radiographic damage with functional outcomes in JRA, illustrating a high correlation for some onset types.
39. Cassidy JT: Osteopenia and osteoporosis in children. Clin Exp Rheumatol 1999, 17:245-250.
40. Lien G, Rato B, Haugen M, et al.: Frequency of osteopenia in adolescents with early-onset juvenile idiopathic arthritis. A long-term outcome study of one hundred five patients. Arthritis Rheum 2003, 48:2214-2223. A very important large Norwegian study demonstrated significant osteopenia in a large cohort of adolescents with JIA.
41. Haugen M, Lien G, Flato B, et al.: Minor impact of juvenile arthritis on nutritional status in young adult patients. Arthritis Rheum 2002, 47:623-629. This study addresses the impact of juvenile arthritis on nutritional status, illustrating that nutritional status is generally good in this population.
42. Oen K, Malleson P, Cabral D, et al.: Early predictors of long-term outcome in patients with juvenile rheumatoid arthritis: subset-specific correlations. J Rheumatol 2003, 30:585-593. This excellent study highlights the early predictors of long-term outcomes in JRA and emphasizes the differences among the various onset types.
43. Van Rossum MJA, Zwinderman AH, Boers M: Radiologic features in juvenile idiopathic arthritis. Arthritis Rheum 2003, 48:507-515. This Dutch study identifies important correlates of radiographic damage in JIA.
44. Al-Matar MJ, Petty RE, Tucker LB, et al.: The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis. Arthritis Rheum 2002, 46:2708-2715. This important Canadian study illustrates the type of joint patterns at onset in pauciarticular JRA that are likely to have a worse outcome.
45. Huemer C, Malleson PN, Cabral D, et al.: Patterns of joint involvement at onset differentiate oligoarticular juvenile psoriatic arthritis from pauciarticular juvenile rheumatoid arthritis. J Rheumatol 2002, 29:1531-1535. Another Canadian study highlights the important differences in joint pattern between pauciarthritis in JRA and that in juvenile psoriatic arthritis.
46. Isenberg DA, Allen E, Farewell V, et al.: International consensus on outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology 2003, 42:1-7. An important study illustrates significant international collaboration in the development of activity and damage indices in the inflammatory myositides.
47. Miller FW, Rider LG, Chung YL, et al.: Proposed core set measures for disease outcome assessment in adult and juvenile idiopathic inflammatory myopathies. Rheumatology 2001, 40:1262-1273.
48. Ruperto N, Ravelli A, Murray KJ, et al.: Preliminary core set of measures for disease activity and damage assessment in juvenile systemic lupus erythematosus and juvenile dermatomyositis. Rheumatology 2003, 42:1-8. This report of an extremely important study describes the methodology and results involved in the determination of the preliminary core set of outcome measures for both JDM and JSLE.
49. Rider L, Giannini EH, Harris-Love M, et al.: Defining clinical improvement in adult and juvenile myositis. J Rheumatol 2003, 30:603-617. This important study highlights the definitions of improvement in the inflammatory myositides.
50. Lovell DJ, Lindsley CB, Rennenbohm RM, et al.: Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies. II. The Childhood Myositis Assessment Scale (CMAS): a quantitative tool for the evaluation of muscle function. The Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1999, 42:2213-2219.
51. Huber AM, Hicks JE, Lachenbruch PA, et al.: Validation of the Childhood Health Assessment Questionnaire in the juvenile idiopathic myopathies. J Rheumatol 2001, 28:1106-1111.
52. Ramanan AV, Feldman BM: Clinical outcomes in juvenile dermatomyositis. Curr Opin Rheumatol 2002, 14:658-662.
53. Brunner HI, Feldman BM, Bombardier C, et al.: The SLEDAI, SLAM and BILAG are sensitive to clinical change in childhood-onset systemic lupus erythematosus. Arthritis Rheum 1999, 42:1354-1360.
54. Brunner HI, Silverman ED, Bombardier C, et al.: European Consensus Lupus Activity Measurement is sensitive to change in childhood-onset systemic onset lupus erythematosus. Arthritis Rheum 2003, 49:335-341. A Canadian study on JSLE demonstrates the usefulness of the European Consensus Lupus Activity Measurement in this population.
55. Brunner HI, Silverman ED, To T, et al.: Risk factors for damage in childhood-onset systemic lupus erythematosus: cumulative disease activity and medication use predict disease damage. Arthritis Rheum 2002, 46:436-444. An important Canadian study on JSLE highlights the degree of damage in JSLE in a large cohort and identifies risk factors for such damage.
56. Ravelli A, Duarte-Salazar C, Buratti S, et al.: Assessment of damage in juvenile-onset systemic lupus erythematosus: a multi-centre cohort study. Arthritis Rheum 2003, 49:501-507. This European study addresses damage and risk factors for damage in JSLE, high-lighting both the consequences of the disease itself and its treatment.